Myrcludex B
Myrcludex B is an experimental drug for the treatment of hepatitis B and D. The hepatitis B virus uses its surface lipopeptide pre-S1 for docking to mature liver cells via their sodium/bile acid cotransporter (NTCP) and subsequently entering the cells. Myrcludex B is a synthetic N-acylated pre-S1 that can also dock to NTCP, blocking the virus’s entry mechanism.
Catalog Number | 10-101-139 |
Alternative Name(s) | Bulevirtide |
Research Area | Myrcludex B is studied for the treatment of HDV. |
CAS# | 406461-66-3 |
Purity | >98% |
Size | Inquiry |
Supplier Page | https://www.creative-peptides.com/product/myrcludex-b-item-10-101-139-34585.html |